Trial · NCT00500266
Results by group61
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 61
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Redness: Any (n=666) | 14.3 | 95% Confidence Interval 11.7 to 17.2 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Redness: Mild (n=660) | 12.6 | 95% Confidence Interval 10.1 to 15.3 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Redness: Moderate (n=649) | 6.5 | 95% Confidence Interval 4.7 to 8.6 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Redness: Severe (n=638) | 1.1 | 95% Confidence Interval 0.4 to 2.2 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Swelling: Any (n=664) | 12.8 | 95% Confidence Interval 10.4 to 15.6 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Swelling: Mild (n=658) | 10.9 | 95% Confidence Interval 8.7 to 13.6 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Swelling: Moderate (n=651) | 5.5 | 95% Confidence Interval 3.9 to 7.6 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Swelling: Severe (n=636) | 0.6 | 95% Confidence Interval 0.2 to 1.6 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Pain: Any (n=777) | 51.0 | 95% Confidence Interval 47.4 to 54.5 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Pain: Mild (n=770) | 49.4 | 95% Confidence Interval 45.8 to 52.9 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Pain: Moderate (n=656) | 9.0 | 95% Confidence Interval 6.9 to 11.4 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Pain: Severe (n=634) | 0.2 | 95% Confidence Interval 0.0 to 0.9 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Limitation of arm movement: Any (n=679) | 16.2 | 95% Confidence Interval 13.5 to 19.2 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Limitation of arm movement: Mild (n=674) | 14.8 | 95% Confidence Interval 12.2 to 17.7 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Limitation of arm movement: Moderate (n=636) | 1.6 | 95% Confidence Interval 0.8 to 2.9 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Limitation of arm movement: Severe (n=640) | 1.6 | 95% Confidence Interval 0.8 to 2.9 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Any local reaction (n=802) | 56.6 | 95% Confidence Interval 53.1 to 60.1 | Percentage of Participants |
| Percentage of Participants With Pre-specified Local Reactions | 13vPnC | Any severe local reaction (n=643) | 2.6 | 95% Confidence Interval 1.5 to 4.2 | Percentage of Participants |
| Percentage of Participants With Pre-specified Systemic Events | 13vPnC | Fever (any): >=38 degrees C (n=641) | 2.0 | 95% Confidence Interval 1.1 to 3.4 | Percentage of Participants |
| Percentage of Participants With Pre-specified Systemic Events | 13vPnC | Fever: >=38 degrees C but <38.5 degrees C (n=636) | 0.8 | 95% Confidence Interval 0.3 to 1.8 | Percentage of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00500266/results